Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Miyazaki

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Physical Chemistry Chemical Physics : PCCP|May 20, 2025
Two-step insertion/release of electrolytic cations in redox-active hydrogen-bonding nanoporous coordination crystalsMakoto Tadokoro, Ryota Nishimura, Hajime Kamebuchi, et al.
In Vivo (Athens, Greece)|October 29, 2022
Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated LiposarcomaNoriyuki Masaki, Yusuke Aoki, Yutaro Kubota, et al.
Urology Case Reports|May 30, 2023
A case of 18 F-FDG- PET positive chronic expanding hematoma in the retroperitoneumAkinobu Katami, Shin-Ichi Hisasue, Hiromichi Sakurai, et al.
In Vivo (Athens, Greece)|October 26, 2021
Osteosarcoma of the Breast in a Patient Derived Orthotopic Xenograft (PDOX) Mouse Model Is Arrested by both Cisplatinum and EribulinNoriyuki Masaki, Nathaniel F Wu, Yusuke Aoki, et al.
Japanese Journal of Clinical Oncology|April 4, 2003
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancerKoji Kawai, Jun Miyazaki, Sadamu Tsukamoto, et al.
BJU International|March 16, 2006
Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signallingJun Miyazaki, Koji Kawai, Takehiro Oikawa, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancerHirofumi Mukai, Shunji Takahashi, Masahiro Nozawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2013
Validation of the prognostic grouping of the seventh edition of the tumor-nodes-metastasis classification using a large-scale prospective cohort study database of prostate cancer treated with primary androgen deprivation therapyTomokazu Kimura, Mizuki Onozawa, Jun Miyazaki, et al.
Japanese Journal of Clinical Oncology|July 17, 2013
Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancerJun Miyazaki, Shiro Hinotsu, Naoki Ishizuka, et al.
FEMS Immunology and Medical Microbiology|May 3, 2002
Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cellsJun Miyazaki, William Ba-Thein, Toshio Kumao, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Physical Chemistry Chemical Physics : PCCP|May 20, 2025
Two-step insertion/release of electrolytic cations in redox-active hydrogen-bonding nanoporous coordination crystalsMakoto Tadokoro, Ryota Nishimura, Hajime Kamebuchi, et al.
In Vivo (Athens, Greece)|October 29, 2022
Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated LiposarcomaNoriyuki Masaki, Yusuke Aoki, Yutaro Kubota, et al.
Urology Case Reports|May 30, 2023
A case of 18 F-FDG- PET positive chronic expanding hematoma in the retroperitoneumAkinobu Katami, Shin-Ichi Hisasue, Hiromichi Sakurai, et al.
In Vivo (Athens, Greece)|October 26, 2021
Osteosarcoma of the Breast in a Patient Derived Orthotopic Xenograft (PDOX) Mouse Model Is Arrested by both Cisplatinum and EribulinNoriyuki Masaki, Nathaniel F Wu, Yusuke Aoki, et al.
Japanese Journal of Clinical Oncology|April 4, 2003
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancerKoji Kawai, Jun Miyazaki, Sadamu Tsukamoto, et al.
BJU International|March 16, 2006
Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signallingJun Miyazaki, Koji Kawai, Takehiro Oikawa, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2014
Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancerHirofumi Mukai, Shunji Takahashi, Masahiro Nozawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2013
Validation of the prognostic grouping of the seventh edition of the tumor-nodes-metastasis classification using a large-scale prospective cohort study database of prostate cancer treated with primary androgen deprivation therapyTomokazu Kimura, Mizuki Onozawa, Jun Miyazaki, et al.
Japanese Journal of Clinical Oncology|July 17, 2013
Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancerJun Miyazaki, Shiro Hinotsu, Naoki Ishizuka, et al.
FEMS Immunology and Medical Microbiology|May 3, 2002
Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cellsJun Miyazaki, William Ba-Thein, Toshio Kumao, et al.
Pageof 17